Literature DB >> 23223495

Tissue distribution and relative gene expression of UDP-glucuronosyltransferases (2B7, 2B15, 2B17) in the human fetus.

Lena Ekström1, Maria Johansson, Anders Rane.   

Abstract

UDP-glucuronosyltransferases (UGTs) catalyze phase II conjugation reactions and play an important role in the inactivation and elimination of several drugs. It is well known that the UGT activity in fetal livers is low compared with the UGT activity in adult livers. In this study the mRNA expression levels of the three human subfamilies, 2B7, 2B15, and 2B17, were determined in 20 adult and 60 fetal liver tissue specimens. The expression profile in fetal kidneys (N = 43), adrenals (N = 46), and lungs (N = 37) was also determined. All fetal and adult samples were genotyped for the UGT2B17 deletion polymorphism. Adult liver contained 13-36 times higher levels of UGT2B mRNAs as compared with fetal livers. UGT2B7 was most abundant in fetal lungs and kidneys, whereas UGT2B15 and UGT2B17 were predominant in the liver. There was a significant correlation between UGT2B7 expression levels in lungs and kidneys, whereas for the other UGT2Bs no correlation between the different tissues was observed. Fetuses expressing two UGT2B17 alleles (ins/ins) displayed significantly higher levels of UGT2B17 mRNA compared to ins/del fetuses in lungs, whereas in the other tissues no gene dose-effect was observed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23223495     DOI: 10.1124/dmd.112.049197

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  14 in total

1.  Genetic variation, expression and ontogeny of sulfotransferase SULT2A1 in humans.

Authors:  L Ekström; A Rane
Journal:  Pharmacogenomics J       Date:  2015-03-24       Impact factor: 3.550

2.  Human hepatic UGT2B15 developmental expression.

Authors:  Karthika Divakaran; Ronald N Hines; D Gail McCarver
Journal:  Toxicol Sci       Date:  2014-06-30       Impact factor: 4.849

3.  The regioselective glucuronidation of morphine by dimerized human UGT2B7, 1A1, 1A9 and their allelic variants.

Authors:  Zi-Zhao Yang; Li Li; Lu Wang; Ling-Min Yuan; Ming-Cheng Xu; Jing-Kai Gu; Hui-di Jiang; Lu-Shan Yu; Su Zeng
Journal:  Acta Pharmacol Sin       Date:  2017-05-29       Impact factor: 6.150

Review 4.  Predicting Human Fetal Drug Exposure Through Maternal-Fetal PBPK Modeling and In Vitro or Ex Vivo Studies.

Authors:  Ankit Balhara; Aditya R Kumar; Jashvant D Unadkat
Journal:  J Clin Pharmacol       Date:  2022-09       Impact factor: 2.860

5.  Blood-Placental Barrier Transfers and Pharmacokinetics of Unbound Morphine in Pregnant Rats with Multiple Microdialysis Systems.

Authors:  I-Hsin Lin; Ling Yang; Thomas Y Hsueh; Tung-Hu Tsai
Journal:  ACS Pharmacol Transl Sci       Date:  2021-08-30

6.  Drug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes?

Authors:  Nina Isoherranen; Kenneth E Thummel
Journal:  Drug Metab Dispos       Date:  2013-02       Impact factor: 3.922

7.  Human Fetal Liver Metabolism of Oxycodone Is Mediated by CYP3A7.

Authors:  Sara Shum; Nina Isoherranen
Journal:  AAPS J       Date:  2021-01-12       Impact factor: 4.009

Review 8.  Targeting inhaled therapy beyond the lungs.

Authors:  Ninell P Mortensen; Anthony J Hickey
Journal:  Respiration       Date:  2014       Impact factor: 3.966

9.  Hepatic Abundance and Activity of Androgen- and Drug-Metabolizing Enzyme UGT2B17 Are Associated with Genotype, Age, and Sex.

Authors:  Deepak Kumar Bhatt; Abdul Basit; Haeyoung Zhang; Andrea Gaedigk; Seung-Been Lee; Katrina G Claw; Aanchal Mehrotra; Amarjit Singh Chaudhry; Robin E Pearce; Roger Gaedigk; Ulrich Broeckel; Timothy A Thornton; Deborah A Nickerson; Erin G Schuetz; John K Amory; J Steven Leeder; Bhagwat Prasad
Journal:  Drug Metab Dispos       Date:  2018-03-30       Impact factor: 3.922

Review 10.  Ontogeny of Drug-Metabolizing Enzymes.

Authors:  Aarzoo Thakur; Md Masud Parvez; J Steven Leeder; Bhagwat Prasad
Journal:  Methods Mol Biol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.